India’s second largest pharmaceutical major Lupin announced on Tuesday that the US Food and Drug Administration had granted it approval to market the generic version of Braintree Laboratories’ Suprep ...
The drug will be available in one strength with a fixed dose to be taken once daily. (File) Global pharma major Lupin Limited on Friday announced the launch of Sodium Sulfate, Potassium Sulfate, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback